Al-Juhaishi T - Search Results

1

Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care center.

Borogovac A, Keruakous A, Bycko M, Holter Chakrabarty J, Ibrahimi S, Khawandanah M, Selby GB, Yuen C, Schmidt S, Autry MT, Al-Juhaishi T, Wieduwilt MJ, Asch AS. Borogovac A, et al. Bone Marrow Transplant. 2022 Jun;57(6):1025-1027. doi: 10.1038/s41409-022-01664-z. Epub 2022 Apr 11. Bone Marrow Transplant. 2022. PMID: 35411106 Free PMC article. No abstract available.

2

CAR-T in B-Cell Lymphomas: The Past, Present, and Future.

Al-Juhaishi T, Ahmed S. Al-Juhaishi T, et al. Clin Lymphoma Myeloma Leuk. 2022 Apr;22(4):e261-e268. doi: 10.1016/j.clml.2021.10.003. Epub 2021 Oct 15. Clin Lymphoma Myeloma Leuk. 2022. PMID: 34782260 Review.

3

Reappraising the Role of Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed and Refractory Hodgkin's Lymphoma: Recent Advances and Outcomes.

Al-Juhaishi T, Borogovac A, Ibrahimi S, Wieduwilt M, Ahmed S. Al-Juhaishi T, et al. J Pers Med. 2022 Jan 18;12(2):125. doi: 10.3390/jpm12020125. J Pers Med. 2022. PMID: 35207613 Free PMC article. Review.

4

Selecting the Optimal CAR-T for the Treatment of B-Cell Malignancies.

Al-Juhaishi T, Ahmed S. Al-Juhaishi T, et al. Curr Hematol Malig Rep. 2021 Feb;16(1):32-39. doi: 10.1007/s11899-021-00615-7. Epub 2021 Feb 25. Curr Hematol Malig Rep. 2021. PMID: 33630232 Review.

5

The Role of Cytoreductive Nephrectomy and Targeted Therapy on Outcomes of Patients With Metastatic Sarcomatoid Renal Cell Carcinoma: A Population-Based Analysis.

Al-Juhaishi T, Deng X, Bandyopadhyay D, Paul A. Al-Juhaishi T, et al. Cureus. 2022 May 27;14(5):e25395. doi: 10.7759/cureus.25395. eCollection 2022 May. Cureus. 2022. PMID: 35774668 Free PMC article.

6

Enhancing antitumor immunity through checkpoint blockade as a therapeutic strategy in T-cell lymphomas.

Neuwelt A, Al-Juhaishi T, Davila E, Haverkos B. Neuwelt A, et al. Blood Adv. 2020 Sep 8;4(17):4256-4266. doi: 10.1182/bloodadvances.2020001966. Blood Adv. 2020. PMID: 32898250 Free PMC article. Review.

7

Outcomes of cardiac diffuse large B-cell lymphoma (DLBCL) in the rituximab era.

Al-Juhaishi T, Al-Kindi SG. Al-Juhaishi T, et al. Int J Cardiol. 2021 Sep 15;339:146-149. doi: 10.1016/j.ijcard.2021.07.043. Epub 2021 Jul 26. Int J Cardiol. 2021. PMID: 34324949

8

Real-world long-term outcomes in multiple myeloma with VRD induction, Mel200-conditioned auto-HCT, and lenalidomide maintenance.

Gaballa MR, Ma J, Tanner MR, Al-Juhaishi T, Bashir Q, Srour SA, Saini NY, Ramdial JL, Nieto Y, Murphy R, Rezvani K, Tang G, Lee HC, Patel KK, Kaufman GP, Manasanch EE, Ullah MR, Kebriaei P, Thomas SK, Weber DM, Orlowski RZ, Shpall EJ, Champlin RE, Qazilbash MH. Gaballa MR, et al. Leuk Lymphoma. 2022 Mar;63(3):710-721. doi: 10.1080/10428194.2021.1992763. Epub 2021 Oct 22. Leuk Lymphoma. 2022. PMID: 34686083

9

Therapy-related myeloid neoplasms in lymphoma survivors: Reducing risks.

Al-Juhaishi T, Khurana A, Shafer D. Al-Juhaishi T, et al. Best Pract Res Clin Haematol. 2019 Mar;32(1):47-53. doi: 10.1016/j.beha.2019.02.008. Epub 2019 Feb 16. Best Pract Res Clin Haematol. 2019. PMID: 30927975 Review.

10

Perspectives on chemotherapy for the management of double-hit lymphoma.

Al-Juhaishi T, Mckay J, Sindel A, Yazbeck V. Al-Juhaishi T, et al. Expert Opin Pharmacother. 2020 Apr;21(6):653-661. doi: 10.1080/14656566.2020.1727445. Epub 2020 Feb 17. Expert Opin Pharmacother. 2020. PMID: 32066288 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters